Drug repurposing for antimicrobial discovery

MA Farha, ED Brown - Nature microbiology, 2019 - nature.com
Antimicrobial resistance continues to be a public threat on a global scale. The ongoing need
to develop new antimicrobial drugs that are effective against multi-drug-resistant pathogens …

Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium

A Arastehfar, T Gabaldón, R Garcia-Rubio, JD Jenks… - Antibiotics, 2020 - mdpi.com
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …

Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition

T Atriwal, K Azeem, FM Husain, A Hussain… - Frontiers in …, 2021 - frontiersin.org
In recent years, the demand for novel antifungal therapies has increased several-folds due
to its potential to treat severe biofilm-associated infections. Biofilms are made by the sessile …

Current antimycotics, new prospects, and future approaches to antifungal therapy

G Wall, JL Lopez-Ribot - Antibiotics, 2020 - mdpi.com
Fungal infections represent an increasing threat to a growing number of immune-and
medically compromised patients. Fungi are eukaryotic organisms and, as such, there is a …

Drug repositioning and repurposing: terminology and definitions in literature

J Langedijk, AK Mantel-Teeuwisse, DS Slijkerman… - Drug discovery today, 2015 - Elsevier
Highlights•Drug repositioning and similar terms have been a trending topic since
2004.•From a legal or regulatory perspective stimulation of drug repositioning requires …

Antifungal therapy with an emphasis on biofilms

CG Pierce, A Srinivasan, P Uppuluri… - Current opinion in …, 2013 - Elsevier
Highlights•Fungal infections affect an expanding population of immunosuppressed
patients.•The current arsenal of antifungal drugs is exceedingly limited.•Toxicity problems …

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …

Screening a repurposing library for inhibitors of multidrug-resistant Candida auris identifies ebselen as a repositionable candidate for antifungal drug development

G Wall, AK Chaturvedi, FL Wormley Jr… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Since its original isolation in 2009, Candida auris has spread across the globe as a
causative agent of invasive candidiasis. C. auris is typically intrinsically resistant to …

Tackling fungal resistance by biofilm inhibitors

S Wu, Y Wang, N Liu, G Dong… - Journal of Medicinal …, 2017 - ACS Publications
The high incidence and mortality of invasive fungal infections and serious drug resistance
have become a global public health issue. The ability of fungal cells to form biofilms is an …

[HTML][HTML] Antifungal therapy of Candida biofilms: Past, present and future

OH Ajetunmobi, H Badali, JA Romo, G Ramage… - Biofilm, 2023 - Elsevier
Virtually all Candida species linked to clinical candidiasis are capable of forming highly
resistant biofilms on different types of surfaces, which poses an additional significant threat …